Skip to content

Clinical trials

Extensively Drug-Resistant Tuberculosis trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Extensively Drug-Resistant Tuberculosis Clear all

23 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20082
20091
20103
20113
20121
20152
20172
20181
20192
20204
20211
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed20
Recruiting1
Terminated1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Global Alliance for TB Drug Development4
National Institute of Allergy and Infectious Diseases (NIAID)4
Medecins Sans Frontieres, Netherlands3
Lisichansk Regional Tuberculosis Dispensary2
Centers for Disease Control and Prevention1
Centre for the AIDS Programme of Research in South Africa1
Harvard School of Public Health (HSPH)1
Médecins Sans Frontières, France1
Nearmedic Plus LLC1
Otsuka Pharmaceutical Development & Commercialization, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Extensively Drug-Resistant Tuberculosis23
Tuberculosis, Multidrug-Resistant22
Tuberculosis17
Tuberculosis, Pulmonary10
Mycobacterium Infections3
Latent Tuberculosis2
Anemia1
Bacterial Infections1
Gram-Positive Bacterial Infections1
Optic Nerve Diseases1

Trials

Showing 1 to 23 of 23. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.